secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2024-08-06T23:59:59+00:00
Accession:  0000950170-24-091938
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ALX Oncology appoints Alan Sandler to Board; Pons and Randolph resign from Board
--------------------------------------------------------------------------------

- Alan Sandler, M.D., appointed to Board effective Aug 5, 2024; receives initial option for 40,400 shares vesting over 36 months.
- Jaume Pons (President/CSO) and Sophia Randolph (CMO) resign from Board to focus on executive roles; no disagreement.
- Board size decreased; now 4 of 5 directors are independent, resolving prior non-compliance with Nasdaq Rule 5605(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000095017024091938/0000950170-24-091938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000095017024091938/alxo-20240805.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-091938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer